Puay Leng Lee Selected Research

Puay Leng Lee Research Topics

9	Neoplasms (Cancer) 01/2021 - 05/2007
7	Breast Neoplasms (Breast Cancer) 11/2020 - 05/2007
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2008
3	Triple Negative Breast Neoplasms 01/2022 - 10/2015
3	Hypoxia (Hypoxemia) 01/2022 - 01/2016
3	Carcinogenesis 01/2016 - 10/2013
2	Neoplasm Metastasis (Metastasis) 11/2015 - 10/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015
1	Leukemia 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 07/2014

5	Histones (Histone)IBA 01/2018 - 05/2007
3	3-deazaneplanocinIBA 01/2015 - 05/2007
2	ChromatinIBA 01/2022 - 05/2007
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2017
2	Polycomb Repressive Complex 2IBA 01/2016 - 05/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2015 - 10/2015
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Deubiquitinating EnzymesIBA 01/2021
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2020
1	Histone DemethylasesIBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Cell-Free Nucleic AcidsIBA 11/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Hypoxia-Inducible Factor 1IBA 01/2016
1	Interleukin-1 Receptor-Associated KinasesIBA 10/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2015
1	Histone Deacetylase InhibitorsIBA 01/2015
1	InterferonsIBA 07/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2013
1	3-Phosphoinositide-Dependent Protein KinasesIBA 10/2013
1	Sirolimus (Rapamycin)FDA Link 11/2010
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	beta CateninIBA 06/2008
1	AdenosylhomocysteinaseIBA 05/2007